Edition:
United Kingdom

AtriCure Inc (ATRC.OQ)

ATRC.OQ on NASDAQ Stock Exchange Global Market

20.57USD
23 Apr 2018
Change (% chg)

$-0.64 (-3.02%)
Prev Close
$21.21
Open
$21.28
Day's High
$21.28
Day's Low
$20.44
Volume
30,113
Avg. Vol
66,720
52-wk High
$25.09
52-wk Low
$14.89

Chart for

About

AtriCure, Inc. is an atrial fibrillation (Afib) solutions company. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. It has various product lines for the ablation of cardiac tissue, including... (more)

Overall

Beta: 0.26
Market Cap(Mil.): $743.98
Shares Outstanding(Mil.): 35.08
Dividend: --
Yield (%): --

Financials

  ATRC.OQ Industry Sector
P/E (TTM): -- 34.82 32.78
EPS (TTM): -0.80 -- --
ROI: -10.65 14.13 13.21
ROE: -15.62 16.91 15.01

BRIEF-Atricure Posts Q4 Loss Per Share $0.08

* ATRICURE REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

26 Feb 2018

BRIEF-Atricure Inc Launches Atriclip Flex V Device In U.S.

* ATRICURE INC - ‍LAUNCHES ATRICLIP FLEX•V DEVICE IN UNITED STATES​ Source text for Eikon: Further company coverage:

22 Feb 2018

BRIEF-Atricure Sees FY 2018 Revenue About $190 Million To $196 Million

* FY2017 REVENUE VIEW $173.9 MILLION -- THOMSON REUTERS I/B/E/S

08 Jan 2018

BRIEF-Atricure reports Q3 loss per share $0.22

* Q3 earnings per share view $-0.24 -- Thomson Reuters I/B/E/S

01 Nov 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $126.83 +0.17
St Jude Medical Inc (STJ.N) -- --

Earnings vs. Estimates